
The impact of pharmaceuticals has been underestimated for many years, but the issue needs to be addressed just as much as the impact of other chemicals, such as pesticides, biocides or industrial chemicals which have a known impact on the environment and human health. The discovery of oestrogen in sewage effluents as a cause of the feminisation of fish in the late 1990s sparked increased interest in the issue of pharmaceuticals in the environment. In 2007, the German Advisory Council on the Environment (SRU, 2007) recommended examining the possibility of including pharmaceuticals in the list of priority hazardous substances1 under the Water Framework Directive. However, in 2018 there is still no pharmaceutical included as a priority substance although it was already proposed by the Expert Group on Review (SG-R) of the Priority Substances in 2009. Alongside other identified relevant substances some pharmaceuticals are now included or proposed to be included on a Watch List to receive more monitoring data.
Briefing continues…
European Environmental Bureau
Rue des Deux Eglises 14-16, B-1000 Brussels
Tel: +32 2 289 10 90
E-mail: eeb@eeb.org
If you have a complaint, please study our complaints policy and contact us at complaints@eeb.org.
EC register for interest representatives: Identification number 06798511314-27
International non-profit association - Association internationale sans but lucratif (AISBL)
BCE identification number: 0415.814.848
RPM Tribunal de l’entreprise francophone de Bruxelles
Funded by the European Union.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or CINEA. Neither the European Union nor CINEA can be held responsible for them.
Find the old website here archive.eeb.org